{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:06:42Z","timestamp":1785409602905,"version":"3.56.0"},"reference-count":36,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82470527"],"award-info":[{"award-number":["82470527"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Project of Tianjin Municipal Health Committee","award":["TJWJ2024RC004"],"award-info":[{"award-number":["TJWJ2024RC004"]}]},{"name":"Science and Technology Project of Tianjin Municipal Health Committee","award":["TJWJ2022MS009"],"award-info":[{"award-number":["TJWJ2022MS009"]}]},{"name":"Key Science and Technology Support Project of Tianjin Science and Technology Bureau","award":["24ZXGZSY00130"],"award-info":[{"award-number":["24ZXGZSY00130"]}]},{"name":"Key Research Project of Tianjin Education Commission","award":["2024ZD031"],"award-info":[{"award-number":["2024ZD031"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-029A"],"award-info":[{"award-number":["TJYXZDXK-029A"]}]},{"name":"Academic Backbone of \u201cClinical Talent Training and Climbing Plan\u201d of Tianjin Medical University, \u201cJinmen Medical Talent\u201d of Tianjin Health Industry High-Level Talent Selection and Training Project","award":["TJSJMYXYC-D2-046"],"award-info":[{"award-number":["TJSJMYXYC-D2-046"]}]},{"name":"National Health Commission Hospital Management Research Project of China","award":["NIHA23JXH009"],"award-info":[{"award-number":["NIHA23JXH009"]}]},{"name":"National Science and Technology Innovation 2030, Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0524300"],"award-info":[{"award-number":["2024ZD0524300"]}]},{"name":"National Science and Technology Innovation 2030, Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0524301"],"award-info":[{"award-number":["2024ZD0524301"]}]},{"name":"Tianjin Municipal Key Research Project in Priority Areas of Traditional Chinese Medicine Project","award":["2022011"],"award-info":[{"award-number":["2022011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background:The prognostic utility of the atherogenic index of plasma (AIP) in patients with coronary artery disease (CAD) and chronic kidney disease (CKD) remains unclear. Therefore, this study aimed to evaluate the association between AIP and long-term outcomes in patients with CAD and stage 2\u20135 CKD.Methods:This retrospective study included 1816 patients with angiographically confirmed CAD and stage 2\u20135 CKD treated at a tertiary center between January 2019 and June 2023. The AIP was calculated as log10 (TG\/HDL-C). The primary endpoint was major adverse cardiac and cerebrovascular events (MACCEs), including cardiac death, non-fatal myocardial infarction (MI), non-fatal stroke, and ischemia-driven revascularization. Patients were stratified into high- and low-AIP groups according to the optimal receiver operating characteristic (ROC) curve-derived cutoff value (0.148). The association between the AIP and incidence of MACCEs was primarily evaluated in the overall cohort using multivariable Cox regression. To minimize the influence of confounding and improve comparability between groups, Kaplan\u2013Meier analysis and model performance metrics, including the C-statistic, net reclassification improvement (NRI), and integrated discrimination improvement (IDI), were also assessed.Results:MACCEs occurred in 379 patients (20.9%). High AIP independently predicted increased risk of MACCEs (adjusted hazard ratio (HR): 1.95; 95% confidence interval (CI): 1.45\u20132.63; p &lt; 0.001). Specifically, the high-AIP group showed a significantly elevated risk of cardiac death (HR: 2.07; 95% CI: 1.13\u20133.80; p = 0.019), non-fatal MI (HR: 1.97; 95% CI: 1.02\u20133.78; p = 0.043), and ischemia-driven revascularization (HR: 2.97; 95% CI: 1.76\u20135.02; p &lt; 0.001). Incorporation of AIP values into the established Global Registry of Acute Coronary Events (GRACE) risk model improved predictive accuracy (C-statistic: 0.624 to 0.679; NRI = 0.139; p = 0.01; IDI = 0.037; p &lt; 0.001) with an optimal AIP cutoff of 0.148 for predicting\u2013MACCEs.Conclusions:AIP is an independent predictor of adverse long-term outcomes in patients with CAD and stage 2\u20135 CKD. Integration of the AIP into existing risk models significantly enhances risk stratification and facilitates the identification of high-risk individuals for personalized management.<\/jats:p>","DOI":"10.31083\/rcm48784","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:31:43Z","timestamp":1785407503000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation Between the Atherogenic Index of Plasma and Major Adverse Long-Term Prognosis in Patients With Coronary Artery Disease and Stage 2\u20135 Chronic Kidney Disease"],"prefix":"10.31083","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1495-1221","authenticated-orcid":true,"given":"Hongya","family":"Liu","sequence":"first","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, 300211 Tianjin, China"},{"name":"Department of Cardiology, Heart Center, Inner Mongolia People\u2019s Hospital, 010017 Hohhot, Inner Mongolia Autonomous Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9890-9522","authenticated-orcid":true,"given":"Jiayi","family":"Ren","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, 300211 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1832-7215","authenticated-orcid":true,"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, 300211 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1720-6788","authenticated-orcid":true,"given":"Xian","family":"Shao","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, 510515 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8356-9611","authenticated-orcid":true,"given":"Jinhua","family":"Zhao","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, 300211 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-6438","authenticated-orcid":true,"given":"Kangyin","family":"Chen","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, 300211 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022; 145: e153\u2013e639.","DOI":"10.1161\/CIR.0000000000001052"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Vora P, Costa A, Rossignol P, Wanner C, Wilson D, Japp S, et al. Incidence of major cardiovascular outcomes in patients with chronic kidney disease by severity: a United States population-based study using electronic medical records. European Heart Journal. 2023; 44: ehad655.2746.","DOI":"10.1093\/eurheartj\/ehad655.2746"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Theofilis P, Vlachakis PK, Karakasis P, Kalaitzidis RG. Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk. Current Atherosclerosis Reports. 2025; 27: 41.","DOI":"10.1007\/s11883-025-01290-2"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Blaum C, Gossling A, Bay B, Arnold N. Inflammation and cholesterol associated residual cardiovascular risk and its dependence on chronic kidney disease in statin treated patients with coronary artery disease. European Heart Journal. 2024; 45.","DOI":"10.1093\/eurheartj\/ehae666.1340"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Colombijn JM, Hooft L, Jun M, Webster AC, Bots ML, Verhaar MC, et al. Antioxidants for adults with chronic kidney disease. The Cochrane Database of Systematic Reviews. 2023; 11: CD008176.","DOI":"10.1002\/14651858.CD008176.pub3"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019; 322: 1294\u20131304.","DOI":"10.1001\/jama.2019.14745"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Rabiee Rad M, Ghasempour Dabaghi G, Darouei B, Amani-Beni R. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease:A systematic review and meta-analysis. Cardiovascular Diabetology. 2024; 23: 119.","DOI":"10.1186\/s12933-024-02198-y"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Kerr AG, Andersson DP, Dahlman I, Ryd\u00e9n M, Arner P. Adipose Insulin Resistance Associates With Dyslipidemia Independent of Liver Resistance and Involves Early Hormone Signaling. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023; 43: 1054\u20131065.","DOI":"10.1161\/ATVBAHA.123.319227"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses. Archives of Medical Research. 2019; 50: 285\u2013294.","DOI":"10.1016\/j.arcmed.2019.08.009"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Liu Z, Zhang L, Wang L, Li K, Fan F, Jia J, et al. The predictive value of cumulative atherogenic index of plasma (AIP) for cardiovascular outcomes: a prospective community-based cohort study. Cardiovascular Diabetology. 2024; 23: 264.","DOI":"10.1186\/s12933-024-02350-8"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Balling M, Nordestgaard BG, Langsted A, Varbo A, Kamstrup PR, Afzal S. Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study. Journal of the American College of Cardiology. 2020; 75: 2873\u20132875.","DOI":"10.1016\/j.jacc.2020.03.072"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Won KB, Heo R, Park HB, Lee BK, Lin FY, Hadamitzky M, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis. 2021; 324: 46\u201351.","DOI":"10.1016\/j.atherosclerosis.2021.03.009"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Onat A, Can G, Kaya H, Hergen\u00e7 G. \"Atherogenic index of plasma\" (log10 triglyceride\/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. Journal of Clinical Lipidology. 2010; 4: 89\u201398.","DOI":"10.1016\/j.jacl.2010.02.005"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Hang F, Chen J, Wang Z, Zheng K, Wu Y. Association between the atherogenic index of plasma and major adverse cardiovascular events among non-diabetic hypertensive older adults. Lipids in Health and Disease. 2022; 21: 62.","DOI":"10.1186\/s12944-022-01670-6"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Liu H, Liu K, Pei L, Li S, Zhao J, Zhang K, et al. Atherogenic Index of Plasma Predicts Outcomes in Acute Ischemic Stroke. Frontiers in Neurology. 2021; 12: 741754.","DOI":"10.3389\/fneur.2021.741754"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Journal of the American Society of Nephrology. 2006; 17: 2937\u20132944.","DOI":"10.1681\/ASN.2006040368"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Selby NM, Taal MW. What every clinician needs to know about chronic kidney disease: Detection, classification and epidemiology. Diabetes, Obesity & Metabolism. 2024; 26 Suppl 6: 3\u201312.","DOI":"10.1111\/dom.15683"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138: e618\u2013e651.","DOI":"10.1161\/CIR.0000000000000617"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Bhatt DL, Lopes RD, Harrington RA. Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022; 327: 662\u2013675.","DOI":"10.1001\/jama.2022.0358"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Turnbull I, Clarke R, Wright N, Guo Y, Kartsonaki C, Pei P, et al. Diagnostic accuracy of major stroke types in Chinese adults: A clinical adjudication study involving 40,000 stroke cases. The Lancet Regional Health. Western Pacific. 2022; 21: 100415.","DOI":"10.1016\/j.lanwpc.2022.100415"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 2021; 143: 1157\u20131172.","DOI":"10.1161\/CIRCULATIONAHA.120.050686"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Deng K, Pan XF, Voehler MW, Cai Q, Cai H, Shu XO, et al. Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations. Journal of the American Heart Association. 2024; 13: e034364.","DOI":"10.1161\/JAHA.124.034364"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovascular Diabetology. 2023; 22: 34.","DOI":"10.1186\/s12933-023-01762-2"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Yang T, Liu Y, Li L, Zheng Y, Wang Y, Su J, et al. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China. Cardiovascular Diabetology. 2022; 21: 93.","DOI":"10.1186\/s12933-022-01531-7"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Reiner \u017d. Hypertriglyceridaemia and risk of coronary artery disease. Nature Reviews. Cardiology. 2017; 14: 401\u2013411.","DOI":"10.1038\/nrcardio.2017.31"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Hu Y, He YM. Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study. Annals of Translational Medicine. 2021; 9: 1030.","DOI":"10.21037\/atm-21-721"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Wang G, Jing J, Wang A, Zhang X, Zhao X, Li Z, et al. Non-High-Density Lipoprotein Cholesterol Predicts Adverse Outcomes in Acute Ischemic Stroke. Stroke. 2021; 52: 2035\u20132042.","DOI":"10.1161\/STROKEAHA.120.030783"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Sehayek D, Cole J, Bj\u00f6rnson E, Wilkins JT, Mortensen MB, Dufresne L, et al. ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk. Journal of Clinical Lipidology. 2025; 19: 844\u2013859.","DOI":"10.1016\/j.jacl.2025.05.024"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Baratta F, Cocomello N, Coronati M, Ferro D, Pastori D, Angelico F, et al. Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk. International Journal of Molecular Sciences. 2023; 24: 4268.","DOI":"10.3390\/ijms24054268"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. Journal of the American Society of Nephrology : JASN. 2007; 18: 304\u2013311.","DOI":"10.1681\/ASN.2006060674"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Ebert T, Qureshi AR, Lamina C, Fotheringham J, Froissart M, Eckardt KU, et al. Time-dependent lipid profile inversely associates with mortality in hemodialysis patients - independent of inflammation\/malnutrition. Journal of Internal Medicine. 2021; 290: 910\u2013921.","DOI":"10.1111\/joim.13291"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Baek J, He C, Afshinnia F, Michailidis G, Pennathur S. Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease. Nature Reviews. Nephrology. 2022; 18: 38\u201355.","DOI":"10.1038\/s41581-021-00488-2"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Dobi\u00e1sov\u00e1 M, Urbanov\u00e1 Z, Sam\u00e1nek M. Relations between particle size of HDL and LDL lipoproteins and cholesterol esterification rate. Physiological Research. 2005; 54: 159\u2013165.","DOI":"10.33549\/physiolres.930565"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovascular Diabetology. 2023; 22: 157.","DOI":"10.1186\/s12933-023-01886-5"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Tim\u00f3teo AT. Is there still a place for improvement in acute coronary syndrome risk stratification? Heart (British Cardiac Society). 2016; 102: 1423\u20131424.","DOI":"10.1136\/heartjnl-2016-309860"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Collet JP, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2021; 42: 1289\u20131367.","DOI":"10.1093\/eurheartj\/ehaa575"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/7\/10.31083\/RCM48784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:32:53Z","timestamp":1785407573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/7\/10.31083\/RCM48784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1530-6550(26)02360-4"],"URL":"https:\/\/doi.org\/10.31083\/rcm48784","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"48784"}}